DFX Intelligence
Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Transactions / A•• B••
A•••••••• C•••••• P••••••• Announces the Acquisition of A•• B••
Platform acquisitionannouncedannounced Jan 5, 2023Fact
What happened
- Target
- A•• B••
- Platform
- not an add-on on record
- Control
- Control
- Share acquired
- unknown
- Industry
- industrials / manufactur
- Target location
- CT, US
- Seller kind
- unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
5 named
Buy side
- “M•••••• L•••••, a Partner at A••••••••, said, “Identifying and investing behind mission-critical inputs within the biologic manufacturing end market has long been an area of focus for A••••••••.”
- “M••• G•••••••••, a Vice President at A••••••••, added, “The combination of the Company’s strong market position, deep customer relationships, and unparalleled expertise in SPF products create an ideal foundation on which to build a new bioprocessing platform.”
- “A•••••••• C•••••• P••••••• Announces the Acquisition of A•• B•• | published on A•••••••• C•••••• P•••••••'s own news page arlingtoncap.com”
Evidence
“A•••••••• C•••••• P••••••• Announces the Acquisition of A•• B••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026